BAP1 genetic testing among melanoma and cancer-prone families in Sweden

References

• Eletr ZM, Wilkinson KD. An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem Biophys. 2011;60(1-2):3–11.
   PubMed Web of Science ®Google Scholar
• Helgadottir H, Hoiom V. The genetics of uveal melanoma: current insights. Appl Clin Genet. 2016;9:147–155.
   PubMedGoogle Scholar
• Jensen DE, Proctor M, Marquis ST, et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998;16(9):1097–1112.
   PubMed Web of Science ®Google Scholar
• Yu H, Pak H, Hammond-Martel I, et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci USA. 2014;111(1):285–290.
   PubMed Web of Science ®Google Scholar
• Yu H, Mashtalir N, Daou S, et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol. 2010;30(21):5071–5085.
   PubMed Web of Science ®Google Scholar
• Ji Z, Mohammed H, Webber A, et al. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex. Nucleic Acids Res. 2014;42(10):6232–6242.
   PubMed Web of Science ®Google Scholar
• Dono M, Angelini G, Cecconi M, et al. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma. Br J Cancer. 2014;110(4):1058–1065.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410–1413.
   PubMed Web of Science ®Google Scholar
• van Essen TH, van Pelt SI, Versluis M, et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol. 2014;98(12):1738–1743.
   PubMed Web of Science ®Google Scholar
• Luchini C, Veronese N, Yachida S, et al. Different prognostic roles of tumor suppressor gene BAP1 in cancer: a systematic review with meta-analysis. Genes Chromosom Cancer. 2016;55(10):741–749.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman MH, Pilarski R, Cebulla CM, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet. 2011;48(12):856–859.
   PubMed Web of Science ®Google Scholar
• Testa JR, Cheung M, Pei J, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43(10):1022–1025.
   PubMed Web of Science ®Google Scholar
• Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43(10):1018–1021.
   PubMed Web of Science ®Google Scholar
• Aoude LG, Wadt K, Bojesen A, et al. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS One. 2013;8(8):e72144.
   PubMed Web of Science ®Google Scholar
• Njauw CN, Kim I, Piris A, et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012;7(4):e35295.
   PubMed Web of Science ®Google Scholar
• Wadt KA, Aoude LG, Krogh L, et al. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition. PLoS One. 2015;10(3):e0122662.
   PubMed Web of Science ®Google Scholar
• Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110(12):1328–1341.
   PubMedGoogle Scholar
• Yelamos O, Navarrete-Dechent C, Marchetti MA, et al. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: results of a multicenter case-control study by the international dermoscopy society. J Am Acad Dermatol. 2019;80(6):1585–1593.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–424.
   PubMed Web of Science ®Google Scholar
• Pissa M, Helkkula T, Appelqvist F, et al. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations. Acta Oncol. 2021;60(7):888–896.
   PubMed Web of Science ®Google Scholar
• Hoiom V, Edsgard D, Helgadottir H, et al. Hereditary uveal melanoma: a report of a germline mutation in BAP1. Genes Chromosom Cancer. 2013;52(4):378–384.
   PubMed Web of Science ®Google Scholar
• Repo P, Jarvinen RS, Jantti JE, et al. Population-based analysis of BAP1 germline variations in patients with uveal melanoma. Hum Mol Genet. 2019;28(14):2415–2426.
   PubMed Web of Science ®Google Scholar
• Kury S, Ebstein F, Molle A, et al. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder. Am J Hum Genet. 2022;109(2):361–372.
   PubMed Web of Science ®Google Scholar
• Potjer TP, Bollen S, Grimbergen A, et al. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families. Int J Cancer. 2019;144(10):2453–2464.
   PubMed Web of Science ®Google Scholar
• O'Shea SJ, Robles-Espinoza CD, McLellan L, et al. A population-based analysis of germline BAP1 mutations in melanoma. Hum Mol Genet. 2017;26(4):717–728.
   PubMed Web of Science ®Google Scholar
• Aoude LG, Gartside M, Johansson P, et al. Prevalence of germline BAP1, CDKN2A, and CDK4 mutations in an Australian Population-Based sample of cutaneous melanoma cases. Twin Res Hum Genet. 2015;18(2):126–133.
   PubMed Web of Science ®Google Scholar
• Ohar JA, Cheung M, Talarchek J, et al. Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer. Cancer Res. 2016;76(2):206–215.
   PubMed Web of Science ®Google Scholar
• Repo P, Staskiewicz A, Sutinen E, et al. BAP1 germline variants in Finnish patients with malignant mesothelioma. Lung Cancer. 2022;165:102–107.
   PubMed Web of Science ®Google Scholar
• Pandithan D, Klebe S, McKavanagh G, et al. BAP1 tumour predisposition syndrome due to whole BAP1 gene deletion. Case Rep Genet. 2022;2022:5503505.
   PubMedGoogle Scholar
• van Meerbeeck JP, Hillerdal G. Screening for mesothelioma: more harm than good? Am J Respir Crit Care Med. 2008;178(8):781–782.
   PubMed Web of Science ®Google Scholar
• Swedish national guidlines familial melanoma. RCC; 2022. https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/hud/vardprogram/hela-bilaga-1.-melanom-familjara-melanom.pdf
   Google Scholar